You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Artificial Pancreas

Showing 1 - 25 of 3,317
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OCT and OCT-A Deep Learning in Diabetic Patients Wiht Artificial

Completed
  • Type 1 Diabetes Mellitus With Artificial Pancreas Device
  • hybrid artificial pancreas systems (CSII)
  • Naples, Italy
    University of Naples "Federico II"
Apr 11, 2023

Diabetes Trial in Wuhan (Artificial pancreas treatment)

Recruiting
  • Diabetes Mellitus
  • Artificial pancreas treatment
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College, Huazhong U
Mar 1, 2023

Among Patients With Type 1 Diabetes Mellitus in China

Recruiting
  • Type 1 Diabetes Mellitus
  • AndroidAPS-rt-CGM;
  • Guangzhou, Guangdong, China
    Jinhua Yan
Oct 12, 2023

Type1 Diabetes Trial in Charlottesville (Neural-net Artificial Pancreas, University of Virginia Model Predictive Control)

Recruiting
  • Type1 Diabetes
  • Neural-net Artificial Pancreas
  • University of Virginia Model Predictive Control
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
May 27, 2023

Diabetes Complications, Diabetes, Type 1, Diabetic Neuropathies Trial in Manchester (Hybrid Closed Loop Insulin Pump)

Not yet recruiting
  • Diabetes Complications
  • +2 more
  • Hybrid Closed Loop Insulin Pump
  • Manchester, United Kingdom
    Manchester Diabetes Centre, Manchester University NHS Foundation
Jul 10, 2023

Diabetes, Type 1 Trial in Arnhem (Bi-hormonal closed-loop control, Open-loop control)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Bi-hormonal closed-loop control
  • Open-loop control
  • Arnhem, Gelderland, Netherlands
    Rijnstate Ziekenhuis
Sep 13, 2022

Type 1 Diabetes Trial in Stanford, Aurora, Charlottesville (AI-based Advisor system)

Not yet recruiting
  • Type 1 Diabetes
  • AI-based Advisor system
  • Stanford, California
  • +2 more
Aug 23, 2023

Type 1 Diabetes Trial in Charlottesville (Artificial Pancreas (AP))

Recruiting
  • Type 1 Diabetes
  • Artificial Pancreas (AP)
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
May 27, 2022

Type 1 Diabetes Trial (Tandem t:slim X2 with Control-IQ Technology, Sensor augmented pump (SAP) therapy)

Not yet recruiting
  • Type 1 Diabetes
  • Tandem t:slim X2 with Control-IQ Technology
  • Sensor augmented pump (SAP) therapy
  • (no location specified)
Dec 15, 2022

Type 1 Diabetes Trial in Valencia (Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and

Not yet recruiting
  • Type 1 Diabetes
  • Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and glucagon) for glucose control
  • Automated insulin delivery system with a single-hormone configuration (insulin) with rescue carbohydrate recommendations for glucose control
  • Valencia, Spain
    INCLIVA
Oct 11, 2023

Type 1 Diabetes Prone to Hypoglycemia Trial in Barcelona (Automated Insulin Delivery System (SAFE-AP))

Completed
  • Type 1 Diabetes Mellitus Prone to Hypoglycemia
  • Automated Insulin Delivery System (SAFE-AP)
  • Barcelona, Spain
    Hospital Clínic de Barcelona
Nov 16, 2022

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Guangzhou (AndroidAPS-rt-CGM;, sensor augmented pump(SAP);)

Recruiting
  • Diabetes Mellitus
  • +6 more
  • AndroidAPS-rt-CGM;
  • sensor augmented pump(SAP);
  • Guangzhou, Guangdong, China
    Jinhua Yan
Feb 12, 2023

Multivariable Artificial Pancreas: Detecting and Mitigating

Recruiting
  • Type 1 Diabetes
    • Chicago, Illinois
      University of Illinois Chicago
    Jul 8, 2022

    Diabetes, Type 1 Trial in London (BiAP, ABC4D)

    Terminated
    • Diabetes Mellitus, Type 1
    • BiAP
    • ABC4D
    • London, United Kingdom
      Imperial College Clinical Research Facility
    Mar 29, 2022

    Diabetes type1 Trial in Nantes, Toulouse (any closed-loop automatic insulin delivery system (or artificial pancreas) CE-marking)

    Completed
    • Diabetes type1
    • any closed-loop automatic insulin delivery system (or artificial pancreas) CE-marking
    • Nantes, France
    • +1 more
    Jul 13, 2022

    Type 1 Diabetes Trial in Montpellier (Artificial Pancreas for DiaPort system with Zone-MPC algorithm)

    Completed
    • Type 1 Diabetes Mellitus
    • Artificial Pancreas for DiaPort system with Zone-MPC algorithm
    • Montpellier, France
      Montpellier University Hospital
    Oct 18, 2021

    Type 1 Diabetes, Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Montreal (Fiasp, Pramlintide Acetate, Placebo)

    Active, not recruiting
    • Type 1 Diabetes
    • +2 more
    • Montreal, Quebec, Canada
      3555 University Street
    Jan 6, 2022

    Type 1 Diabetes Trial in Stanford, Aurora, Charlottesville (Tandem t:slim X2 with Control-IQ Technology Pro, Standard Care (SC),

    Completed
    • Type 1 Diabetes
    • Tandem t:slim X2 with Control-IQ Technology Pro
    • +2 more
    • Stanford, California
    • +2 more
    Oct 7, 2022

    Diabetes, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia Trial in Montreal (Rapid-Acting Insulin, Placebo, Pramlintide

    Recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • Rapid-Acting Insulin
    • +3 more
    • Montreal, Quebec, Canada
      McGill University Health Centre
    Dec 9, 2021

    Type1 Diabetes Trial in New Haven (CL/AP system, usual diabetic care)

    Terminated
    Has Results
    • Type1 Diabetes Mellitus
    • CL/AP system
    • usual diabetic care
    • New Haven, Connecticut
      Yale New Haven Hospital
    Nov 16, 2022

    Type1 Diabetes Trial in New Haven (Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP))

    Completed
    Has Results
    • Type1 Diabetes
    • Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP)
    • New Haven, Connecticut
      Yale University
    May 11, 2022

    Type 1 Diabetes Trial in Montreal (Physical activity trial intervention)

    Not yet recruiting
    • Type 1 Diabetes
    • Physical activity trial intervention
    • Montreal, Quebec, Canada
      Institut de recherches cliniques de Montréal
    Apr 6, 2023

    Breaking Disparities in Access to Advanced Diabetes Technologies

    Recruiting
    • Diabetes Mellitus, Type 1
    • +3 more
    • Advanced artificial pancreas closed-loop technology
    • Jacksonville, Florida
    • +1 more
    May 7, 2023

    HCL Insulin Delivery System on Glycemic Control in T1D

    Recruiting
    • Diabetes Mellitus, Type 1
    • Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6
    • MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4
    • Usti Nad Labem, Czechia
      Lucie Radovnická
    Jun 21, 2023

    Type 1 Diabetes Trial in Santa Barbara (Investigational inhaled insulin (Technosphere), Artificial Pancreas (AP) device (APS©))

    Completed
    Has Results
    • Type 1 Diabetes Mellitus
    • Investigational inhaled insulin (Technosphere)
    • Artificial Pancreas (AP) device (APS©)
    • Santa Barbara, California
      Sansum Diabetes Research Institute
    Oct 14, 2021